Skip to content

OM — Hedge Fund Holders & Catalysts | BiotechEdge

BiotechEdge New: AI Signals

Catalysts Convergence Squeeze Signals Cash Runway Insiders M&A Research

Sign In Start 14-Day Free Trial

Home›Companies›Outset Medical, Inc. (OM)

Outset Medical, Inc.

OM

Held by 1 specialist biotech fund

1 fund opened new positions.

Share

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Perceptive AdvisorsNew

AI Signal

Signal Note: Perceptive Advisors Initiates OM Position

Perceptive's $3.1M entry into Outset Medical (dialysis device/software platform) signals conviction in the company's commercial execution and potential M&A appeal in the dialysis/kidney care space. OM has modest cash runway concerns typical of medical device companies, but the initiation by a manager with strong clinical-stage execution track record suggests confidence in near-term milestones or revenue inflection—worth monitoring for Q-level cash burn trends and any partnerships that could extend runway without significant dilution.

Unlock full AI analysis — 14-day free trial

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/APerceptive Advisors6.7%May 15, 2025

SC 13GPerceptive Advisors9.5%Feb 28, 2025

Position Details

Perceptive AdvisorsNEWFeb 17, 2026

Start free trialfor share counts, dollar values & AI analysis

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Insider Signals

No insider purchases or sales detected in the past 90 days.

Also Held by These Funds

AAVXF1 fund BLLN1 fund ADMA1 fund AMLX1 fund AQST1 fund DXCM1 fund XFOR1 fund GOSS1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: